Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Carissa Chu(University of California, San Francisco), Jonathan Chou(University of California, San Francisco)

Clinical Cancer Research

June 9, 2021

10.1158/1078-0432.ccr-20-4175

Cited by 154

Related Papers

Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer

|Cancer Research|2022|58

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer

|Nature Communications|2025|7